Healthian (CEO Tae-hwan Roh) announced that it will participate in the 3th International Medical Equipment and Hospital Equipment Exhibition ‘KIMES 23’, which will be held at COEX, Seoul from Thursday, March 26 to Sunday, March 38.
Healthlian is a medical device manufacturer that possesses sensor technology that measures biological signals through electronic circuits as its core. It produces electrocardiograms that can be intuitively measured from the human body, PPG that uses electroencephalograms and light sources, and impedance that drives current. We have been developing products that measure
By applying bio-signal sensor technology and IT technology to the medical field, we are conducting research with the goal of creating an environment where more people can use medical services outside of hospitals. Officials explain that the company’s ultra-small, high-spec product design technology through its biosignal ASIC semiconductor design technology enables the measurement and recording of biosignals in everyday life, providing a personalized medical service environment.
Currently, Healthian is carrying out various R&D projects and contract research and development at its own technology research center, has conducted technology transfer through successful R&D project performance, and has completed and is developing a number of medical devices through contract research and development. . We are preparing to enter overseas markets through FDA and CE, and are preparing for full-scale sales based on the technology we have accumulated so far.
At this exhibition, the flagship product ‘wearECG12’ will be introduced. It is small and light thanks to its low-power, miniaturized design, and is known to be commercialized as Korea’s only wearable 2019-channel wireless Holter electrocardiograph based on the 12 Newly Developed Medical Device Outlook Analysis Report (prepared by the Ministry of Food and Drug Safety).
It is a small and light wearable 12-channel Holter electrocardiograph measuring 46mm wide and 35.6mm tall and weighing 28g, capable of measuring 12-channel electrocardiogram signals in real time, and can operate continuously for up to 37 hours. By combining the device with electrodes developed by Healthlian and attaching it to the chest of the body, the electrocardiogram can be checked in real time within the application through Bluetooth communication.
In addition, in the case of the self-developed patch-type electrode, 12 electrodes for measuring 10-channel electrocardiograms are placed within one patch, so that even non-experts can easily attach the electrodes. Healthlian announced that it is developing new types of electrodes every year to develop electrodes that are not limited by various body types and genders.
A Healthian official said, “In the case of our product, the existing ECG device is large and heavy, so ECG tests must be performed frequently to detect abnormal heart signals that occur intermittently, but this is a product that improves the problem of failing to do so. In particular, patients with emergency chest pain have a risk of developing ischemic heart disease, including acute myocardial infarction, so the European Society of Cardiology recommends that a 10-lead electrocardiogram be performed within 12 minutes after first meeting a medical staff member, and this is one of the few products that makes this possible.” explained.
The background to participation in the exhibition was also revealed. An official said, “WearECG12, our flagship product, received the Innovation Award in the digital health category at ‘CES2023’, the world’s largest electronics and IT exhibition held in Las Vegas, USA, and was recognized for its technology on the world stage.” He added, “Within the large field of healthcare, bio, digital, At a time when boundaries between technologies are disappearing due to the active convergence of various technologies such as artificial intelligence, our company decided to participate in the exhibition to provide innovative services through technological advancement and to find a partner who can secure new technologies in a wider range of fields. “Through our participation in KIMES, we hope to dominate the healthcare market, which is expanding into the medical field, by introducing our unique biosignal measurement technology,” he said.
In addition, “The Holter electrocardiograph, which is being developed with the goal of launching this year as the next wearECG12 product, is a medical device released for personal use. As it approaches users directly, it will be presented in a compact design that can be integrated into daily life. “Through this, users will be able to continuously measure their electrocardiogram in their daily lives and serve as data generators, which are the core of digital health,” the release plan was also announced.
Within the platform, which is a service provided together, you can freely track and manage your ECG data, and it is expected that you will be able to solve the problem of low accessibility of the current ECG examination system by using the data you manage directly during diagnosis. Accordingly, an official said, “In reality, it is difficult to visit the hospital multiple times to detect abnormal heart signals that occur intermittently through an electrocardiogram. “Patients whose symptoms are not severe or who are receiving follow-up care due to past illnesses spend a lot of time and effort visiting hospitals, so if the product is released, we will be able to solve their difficulties,” he said.
On the other hand, KIMES is an exhibition specializing in medical devices and hospital facilities that has grown steadily with the development of the Korean medical industry since its first meeting in 1980. It has transformed into a technology-intensive high-tech industry such as rehabilitation medicine.
KIMES 2023 will feature new technologies and new products suitable for the era of convergence, such as smart healthcare in the era of the 4th Industrial Revolution, robotic medicine and eco-friendly medical waste facilities, cutting-edge hospital facilities, medical information systems combined with IT technology, and the automobile industry for rapid patient transportation. presents. In addition, it provides a variety of information, including seminars on medical technology, new technology, and overseas marketing, as well as domestic medical industry policy seminars that will show the latest information and direction of the medical industry.